Immunohistochemical analysis of human lung cancers with anti-ras p21 monoclonal antibodies.

The expression of ras oncogene product p21 in human malignant pleurisy and primary lung cancer was studied immunocyto-histochemically with monoclonal antibodies (MoAbs) rp-28 and rp-35 against ras p21. In pleural effusion cells, cancer cells revealed more intensively positive reaction with MoAb rp-35 than with MoAb rp-28, especially in the plasma membrane, and no positive reaction was obtained in any kind of inflammation cells with the exception of faintly positive reaction in the cytoplasm of macrophages. In primary lung cancers, well or moderately differentiated adenocarcinoma tissues showed higher reactivity with MoAb rp-28 than those of poorly differentiated adenocarcinoma or any other histological subtype of lung cancer. With MoAb rp-35, intensively positive reaction was obtained in most of cases with all different histological subtypes of lung cancer. The staining in cancer cells was usually localized intensively to the plasma membrane and weakly to the cytoplasm with both MoAbs. Normal bronchial epithelial and glandular tissues showed only cytoplasmic staining. These two MoAbs, especially MoAb rp-35, may be useful in clinicopathological applications for the diagnosis of malignant pleurisy and primary lung cancer.
AuthorsH Dosaka, M Harada, N Kuzumaki, H Kobayashi, H Isobe, H Miyamoto, Y Kawakami
JournalThe International journal of biological markers (Int J Biol Markers) 1987 May-Aug Vol. 2 Issue 2 Pg. 75-82 ISSN: 0393-6155 [Print] ITALY
PMID3330557 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Proto-Oncogene Proteins
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)
  • Antibodies, Monoclonal
  • Cell Line
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms (analysis)
  • Pleural Effusion
  • Proto-Oncogene Proteins (analysis)
  • Proto-Oncogene Proteins p21(ras)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: